Mometasone
Sponsors
Insmed Inc., HAL Allergy B.V., Eli Lilly & Co., Universitair Ziekenhuis Gent, Organon and Co
Conditions
Allergic RhinitisAsthmaChronic Rhinosinusitis With Nasal Polyps (CRSwNP)Chronic Rhinosinusitis without Nasal Polyps (CRSsNP)Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis with or without Asthma Induced by House Dust Mite (HDM) AllergyOtitis Media With EffiusionPerennial Allergic RhinitisPerennial Allergic Rhinitis (PAR)
Phase 1
Phase 2
Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2
CompletedNCT03758950
Start: 2018-11-29End: 2023-05-31Updated: 2023-06-18
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants with Chronic Rhinosinusitis Without Nasal Polyps – The BiRCh Study
CompletedCTIS2022-502481-24-00
Start: 2024-05-23End: 2025-10-29Target: 203Updated: 2025-05-14
Phase 3
A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)
CompletedNCT00783224
Start: 2005-09-30End: 2005-12-31Updated: 2022-02-09
Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray
CompletedNCT01401465
Start: 2011-07-31End: 2011-11-30Updated: 2013-04-30
Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children
CompletedNCT02541760
Start: 2014-04-30End: 2015-04-30Updated: 2015-09-04
Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis
CompletedNCT05311475
Start: 2022-04-04End: 2023-06-20Updated: 2023-07-11
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects with Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis with or without Asthma Induced by House Dust Mite (HDM) Allergy
Active, not recruitingCTIS2023-504942-75-01
Start: 2024-08-22Target: 582Updated: 2025-12-16
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/LY3650150 in Participants with Chronic Rhinosinusitis with Nasal Polyps on Background Intranasal Corticosteroids
RecruitingCTIS2023-508760-29-00
Start: 2024-10-21Target: 231Updated: 2025-09-22
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/ LY3650150 in Adult Participants With Perennial Allergic Rhinitis
RecruitingCTIS2023-508817-18-00
Start: 2024-10-08Target: 258Updated: 2025-10-20
Phase 4
Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)
CompletedNCT00070707
Start: 2003-04-03End: 2003-11-26Updated: 2024-09-05
Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis
TerminatedNCT00361439
Start: 2006-08-31End: 2008-09-30Updated: 2014-02-28
A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma
TerminatedNCT00461812
Start: 2007-04-30End: 2010-01-19Updated: 2017-09-20
Elocon vs Fluticasone in Localized Psoriasis (P03197)
CompletedNCT00763529
Start: 2003-01-01End: 2005-01-01Updated: 2024-08-15
Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)
CompletedNCT00783237
Start: 2003-12-01End: 2004-02-21Updated: 2024-08-15
Characterisation and intervention study in patients with long-term use of nasal decongestants.
CompletedCTIS2024-516312-25-00
Start: 2024-09-05End: 2025-04-30Target: 135Updated: 2024-09-05